Patterns of FOXE 1 Expression in Papillary Thyroid Carcinoma

Title Patterns of FOXE1 Expression in Papillary Thyroid Carcinoma by Immunohistochemistry Author(s) Bychkov, Andrey; Saenko, Vladimir; Nakashima, Masahiro; Mitsutake, Norisato; Rogounovitch, Tatiana; Nikitski, Alyaksandr; Orim, Florence; Yamashita, Shunichi Citation Thyroid, 23(7), pp.817-828; 2013 Issue Date 2013-07-08 URL http://hdl.handle.net/10069/33884 Right This is a copy of an article published in the Thyroid © 2013 Mary Ann Liebert, Inc.; Thyroid is available online at: http://online.liebertpub.com. NAOSITE: Nagasaki University's Academic Output SITE

[1]  E. Duncan,et al.  Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. , 2012, The Journal of clinical endocrinology and metabolism.

[2]  Keesook Lee,et al.  Suppression of estrogen receptor-alpha transactivation by thyroid transcription factor-2 in breast cancer cells. , 2012, Biochemical and biophysical research communications.

[3]  P. Gattuso,et al.  Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. , 2012, Endocrine-related cancer.

[4]  P. Santisteban,et al.  Role of the Wnt Pathway in Thyroid Cancer , 2012, Front. Endocrin..

[5]  A. Auton,et al.  Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24 , 2012, Journal of Medical Genetics.

[6]  M. Santoro,et al.  Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters. , 2011, Thyroid : official journal of the American Thyroid Association.

[7]  H. Kaida,et al.  Relation between 99mTc-tetrofosmin thyroid scintigraphy and mitogen-activated protein kinase in papillary thyroid cancer patients , 2011, Japanese Journal of Radiology.

[8]  Hwa-Young Lee,et al.  Downregulation of Foxe1 by HR suppresses Msx1 expression in the hair follicles of Hr(Hp) mice. , 2011, BMB reports.

[9]  T. Kawaguchi,et al.  The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population , 2011, Journal of Medical Genetics.

[10]  W. Lee,et al.  Matrix Metalloproteinase-2 and -7 Expression in Colorectal Cancer , 2011, Journal of the Korean Society of Coloproctology.

[11]  Y. Nikiforov.  Molecular analysis of thyroid tumors , 2011, Modern Pathology.

[12]  M. de Felice,et al.  MSX1 and TGF-beta3 are novel target genes functionally regulated by FOXE1. , 2011, Human molecular genetics.

[13]  S. Heath,et al.  The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. , 2010, Human molecular genetics.

[14]  D. Teti,et al.  FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma , 2010, The British journal of dermatology.

[15]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[16]  M. Pelizzo,et al.  The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors , 2009, PLoS genetics.

[17]  Kari Stefansson,et al.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations , 2009, Nature Genetics.

[18]  H. Andreyev,et al.  Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67 , 2008, Journal of Clinical Pathology.

[19]  M. Rivera,et al.  Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms , 2008, Modern Pathology.

[20]  H. Baik,et al.  High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. , 2007, Thyroid : official journal of the American Thyroid Association.

[21]  Moon-Kyu Lee,et al.  USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. , 2007, Endocrine journal.

[22]  D. McMillin,et al.  Targeting BRAFV600E in thyroid carcinoma: therapeutic implications , 2007, Molecular Cancer Therapeutics.

[23]  A. Miyauchi,et al.  Lack of association between BRAF V600E mutation and mitogen‐activated protein kinase activation in papillary thyroid carcinoma , 2007, Pathology international.

[24]  P. Hasleton,et al.  Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports , 2006, Histopathology.

[25]  Michael A. Gonzalez,et al.  Mcm‐2 and Ki‐67 Have Limited Potential in Preoperative Diagnosis of Thyroid Malignancy , 2006, The Laryngoscope.

[26]  T. Eimoto,et al.  Cell proliferation marker MCM2, but not Ki67, is helpful for distinguishing between minimally invasive follicular carcinoma and follicular adenoma of the thyroid , 2006, Histopathology.

[27]  Ping Zhang,et al.  Immunohistochemical analysis of thyroid‐specific transcription factors in thyroid tumors , 2006, Pathology international.

[28]  S. Krüger,et al.  Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. , 2005, Kidney international.

[29]  H. Namba,et al.  Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant β‐catenin expression , 2005, Histopathology.

[30]  C. Missero,et al.  Requirement of the forkhead gene Foxe1, a target of sonic hedgehog signaling, in hair follicle morphogenesis. , 2004, Human molecular genetics.

[31]  J. Chan,et al.  Subcellular Localization of Immunohistochemical Signals , 2004, International journal of surgical pathology.

[32]  A. Frischauf,et al.  FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma. , 2004, The Journal of investigative dermatology.

[33]  Se Hoon Kim,et al.  Expression of down stream molecules of RET (p-ERK, p-p38 MAPK, p-JNK and p-AKT) in papillary thyroid carcinomas. , 2004, Yonsei medical journal.

[34]  B. Jasani,et al.  Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis. , 2003, Thyroid : official journal of the American Thyroid Association.

[35]  J. Cameron,et al.  Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. , 2003, Cancer research.

[36]  R. Henriksson,et al.  Spatial Expression of VEGF-A in Human Glioma , 2002, Journal of Neuro-Oncology.

[37]  B. Jasani,et al.  Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. , 2001, Thyroid : official journal of the American Thyroid Association.

[38]  V. Chatterjee,et al.  Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia , 1998, Nature Genetics.

[39]  M. Matsui,et al.  Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[40]  M. Arnone,et al.  TTF‐2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation , 1997, The EMBO journal.

[41]  B. Chadwick,et al.  FKHL15, a new human member of the forkhead gene family located on chromosome 9q22. , 1997, Genomics.

[42]  A. Saiardi,et al.  Purification and characterization of thyroid transcription factor 2. , 1994, The Biochemical journal.

[43]  R. Lauro,et al.  Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity. , 1993, Molecular endocrinology.

[44]  R. Marcos,et al.  Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma. , 2010, Cancer biomarkers : section A of Disease markers.

[45]  Leslie H. Sobin,et al.  TNM Classification of Malignant Tumours, 7th Edition , 2009 .

[46]  A. Harris,et al.  Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1α expression , 2006, Modern Pathology.

[47]  N. Gale,et al.  Expression of CD34, alpha-smooth muscle actin, and transforming growth factor beta1 in squamous intraepithelial lesions and squamous cell carcinoma of the larynx and hypopharynx. , 2005, Human pathology.

[48]  M. Polak,et al.  PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. , 2005, The Journal of clinical endocrinology and metabolism.

[49]  P. Allavena,et al.  Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells , 2000 .

[50]  W. Hohenberger,et al.  Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. , 1998, Pathology, research and practice.